the effect of nicardipine hydrochloride , a calcium-channel blocking agent , was studied in 46 patients with stable angina in a double-blind , placebo-controlled , randomized , repeated cross-over protocol , using a 30 or 40 mg dose of nicardipine or placebo three times a day .
C0770150
nicardipine hydrochloride
C0028005
nicardipine